An Etiologic Perspective of the New Herpesviruses: HHV-7 and HHV-8

Infections in Medicine

Volumn 16, Issue 1, 1999, Pages 24-33

  Levine, Paul H ^a,c   Ablashi, Dharam V ^b,d  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Advanced Biotechnologies Inc   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Exanthema subitum; Human herpesvirus 7 (HHV 7); Human herpesvirus 8 (HHV 8); Kaposi's sarcoma

Indexed keywords

EID: 0002588798     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994.
2. Whitby D, Howard MR, Tenant-Flowers M, et al: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802, 1995.
3. Cesarman E, Moore PS, Rao PH, et al: In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708-2714, 1995.
4. Roisman B: New viral footprints in Kaposi's sarcoma. N Engl J Med 332:1227-1228, 1995.
5. Dupin N, Grandadam M, Calvez V, et al: Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345:761-762, 1995.
6. Soulier J, Grollet L, Oksenhendler E, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995.
7. Moore PS, Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 332:1181-1185, 1995.
8. Foreman KE, Friborg J, Kong W, et al: Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 338:163-171, 1997.
9. Levine PH, Blattner WA: The epidemiology of human virus-associated hematologic malignancies: Leukemia and related diseases. Leukemia 6(suppl 3):S54-S59, 1992.
10. de Thé G: The epidemiology of Burkitt's lymphoma: Evidence for a causal association with Epstein-Barr virus. Epidemiol Rev 1:32-54, 1979.
11. de Thé G, Ho JHC, Muir CS: Nasopharyngeal carcinoma, in Evans AS (ed): Viral Infections of Humans: Epidemiology and Control, ed 3. New York, Plenum Publishing Corp, 1991, pp 737-767.
12. Lee ES, Locker J, Nalesnik M, et al: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19-25, 1995.
13. McClain KL, Leach CT, Jenson HB, et al: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12-18, 1995.
14. Levine PH: A review of human herpesvirus-6 infections. Infect Med 12:395-402, 1995.
15. Luppi M, Torelli G: The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: An overview. Haematologica 81:265-281, 1996.
16. Yadav M, Chandrashekran A, Vasudevan DM, et al: Frequent detection of human herpesvirus 6 in oral carcinoma. J Natl Cancer Inst 86:1792-1794, 1994.
17. Timmons CF, Dawson DB, Richards CS, et al: Epstein-Barr virus-associated leiomyosarcomas in liver transplantation recipients. Cancer 76:1481-1489, 1995.
18. Frenkel N, Schirmer EC, Wyatt LS, et al: Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci U S A 87:748-752, 1990.
19. Asano Y, Suga S, Yoshikawa T, et al: Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics 95:187-190, 1995.
20. Ablashi DV, Berneman ZN, Kramarsky B, et al: Human herpesvirus-7 (HHV-7): Current status. Clinical and Diagnostic Virology 4:1-13, 1995.
21. Yoshikawa T, Asano Y, Kobayashi I, et al: Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol 41:319-323, 1993.
22. Wyatt LS, Rodriguez WJ, Balachandram N, et al: Human herpesvirus 7: Antigenic properties and evidence in children and adults. J Virol 65:6260-6265, 1991.
23. Clark DA, Freeland JML, Makie PLN, et al: Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 168:251-252, 1993.
24. Berneman ZN, Gallo RC, Ablashi DV, et al: Human herpesvirus-7 (HHV-7) strain JI: Independent confirmation of HHV-7. J Infect Dis 166:690-691, 1992.
25. Black JB, Inoue N, Kite-Powell K, et al: Frequent isolation of human herpesvirus 7 from saliva. Virus Res 29:91-98, 1993.
26. Hashida T, Komura E, Yoshida M, et al: Hepatitis in association with human herpesvirus-7 infection. Pediatrics 96:783-785, 1995.
27. Hidaka Y, Liu Y, Yamamoto M: Frequent isolation of human herpesvirus 7 from saliva samples. J Med Virol 40:343-346, 1993.
28. Wyatt LS, Frenkel N: Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 66:3206-3209, 1992.
29. Tanaka-Taya K, Kondo T, Mukai T, et al: Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol 48:88-94, 1996.
30. Berneman ZN, Ablashi DV, Fletcher ME, et al: Human herpesvirus-7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus-6 and human cytomegalovirus. Proc Natl Acad Sci U S A 80:10552-10556, 1992.
31. Suga S, Yoshikawa T, Nagai T, et al: Clinical features and virological findings in children with primary human herpesvirus-7 infection. Pediatrics 99:468-469, 1994.
32. Kawa-Ha K, Tanaka K, Inour M, et al: Isolation of human herpesvirus-7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. J Hematol 84:345-548, 1993.
33. Yalcin S, Karpuzoglu T, Suleymanler G, et al: Human herpesvirus-6 and -7 infections in renal transplant patients and healthy adults in Turkey. Arch Virol 136:183-190, 1994.
34. Nicholas J: Determination and analysis of the complete nucleotide sequence of human herpesvirus-7. J Virol 70:5975-5989, 1996
35. Singer D, Frenkel N: Human herpesvirus 7 (HHV-7) DNA: Analyses of clones spanning the entire genome. Arch Virol 142(2):287-303, 1997.
36. Roisman B, Desrosiers RE, Fleckenstein B, et al: The family herpesviridae: An update. Arch Virol 123:426-449, 1992.
37. Schmidt CW, Misko IS: The ecology and pathology of Epstein-Barr virus. Immunol Cell Biol 73:489-504, 1995.
38. Miller G: Epstein-Barr virus: Biology, pathogenesis and medical aspects, in Fields BN, Knipe DM, Chanock RM, et al (eds): Fields Virology. New York, Raven Press, 1990, pp 1921-1958.
39. Mesri EA, Cesarman E, Arvanitakis L, et al: Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183:2385-2390, 1996.
40. Strauchen JA, Hauser D, Burstein D, et al: Body cavity-based malignant lymphoma cells containing Kaposi's sarcoma herpesvirus in an HIV-negative man with previous Kaposi's sarcoma. Ann Intern Med 125:822-825, 1996.
41. Pacheco-Castro A, Marquez C, Toribio ML, et al: Herpesvirus saimiri immortalization of alpha-beta and gamma-delta human T-lineage cells derived from CD34+ intrathymic precursors in vitro. Int Immunol 8:1797-1805, 1996.
42. Flore O, Rafii S, Ely S, et al: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592, 1998.
43. Drago F, Ranieri E, Maaguti F, et al: Human herpesvirus 7 in patients with pityriasis rosea: Electron microscopy investigations and polymerase reaction in mononuclear cells, plasma and skin. Dermatology 195:374-378, 1997.
44. Salahuddin SZ, Ablashi DV, Markham PD, et al: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601, 1986.
45. Pearson GR: Epstein-Barr virus: Immunology, in Klein G (ed): Viral Oncology. New York, Raven Press, 1980, pp 739-767.
46. Lennette ET, Blackbourn DJ, Levy JA: Antibodies to HHV-8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858-861, 1996.
47. Lin S-F, Sun R, Heston L, et al: Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 71:3069-3076, 1997.
48. Gao SJ, Kingsley L, Li M, et al: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925-928, 1996.
49. Kedes DH, Ganem D, Ameli N, et al: The prevalence of serum antibody to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 277:478-481, 1997.
50. Chang Y, Moore PS: Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5:215-222, 1996.
51. Simpson GA, Schultz T, Whitby D, et al: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133-1138, 1996.
52. Buonaguro FM, Tornesello ML, Beth-Giraldo E, et al: Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28, 1996.
53. Gottlieb G, Ackerman AB (eds): Kaposi's Sarcoma: A Text and Atlas. Philadelphia, Lea and Febiger, 1988, pp 1-329.
54. Templeton AC: Studies in Kaposi's sarcoma: Postmortem findings and disease patterns in women. Cancer 30:854-867, 1972.
55. Davies JNP, Lothe F: Kaposi's sarcoma in African children, in Ackerman LV, Hurray JF (eds): Symposium on Kaposi's Sarcoma. Basel, Switzerland, S. Karger, 1983, pp 81-86.
56. Friedman-Kien AE, Laubenstein LJ, Rubinstein P, et al: Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med 96:693-700, 1982.
57. Beral V, Peterman TA, Berkelman RI, et al: Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 335:123-128, 1990.
58. Peterman TA, Jaffe HW, Beral V: Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS 7:605-611, 1993.
59. Des Jarlais DC, Marmor M, Thomas P, et al: Kaposi's sarcoma among four different AIDS risk groups. N Engl J Med 310:1119, 1984. Letter.
60. Bary M, Vittecoq D, Liotier JY, et al: Heterosexual transmission of the aetiological agent of Kaposi's sarcoma. Lancet 337:234, 1991. Letter.
61. Blackbourn DJ, Ambroziak J, Lennette E, et al: Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 349:609-611, 1997.
62. Levy JA: Three new human herpesviruses (HHV6, 7, and 8). Lancet 349:558-563, 1997.
63. Cesarman E, Chang Y, Moore PS, et al: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191, 1995.
64. Knowles DM, Inghirami G, Ubriaco A, et al: Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of Epstein-Barr virus. Blood 73:792-799, 1989.
65. Rywlin AM, Rosen L, Cabello B: Coexistence of Castleman's disease and Kaposi's sarcoma: Report of a case and speculation. Am J Dermatopathol 5:277-279, 1983.
66. Kedes DH, Operskalski E, Busch M, et al: The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk goups and evidence for sexual transmission. Nat Med 2:918-924, 1996.
67. Goedert JJ, Kedes DH, Ganem D: Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA. Lancet 10:1368, 1997.